This question became even more evident when Swisher et al (2008) showed that acquired resistance to platinum compounds in BRCA1-mutated human ovarian tumours is associated with secondary mutations in BRCA1 that restore the open-reading frame in platinum-resistant tumours. The gene discussed is BRCA1; the disease is neoplasm.